Active Ingredient: CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL
Proprietary Name: EXOSURF NEONATAL
Dosage Form; Route of Administration: FOR SUSPENSION; INTRATRACHEAL
Strength: 12MG/VIAL;108MG/VIAL;8MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020044
Product Number: 001
Approval Date: Aug 2, 1990
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:
Discontinued
Patent and Exclusivity Information
